Clinical Trial

Unipolar Voltage Mapping for Personalized Atrial Fibrillation Ablation

Study acronym: UNIQS-AF
Recruiting
View on ClinicalTrials.gov →
Summary
Atrial fibrillation (AF) is a common heart rhythm disorder. While catheter ablation is an effective treatment, many patients still experience AF recurrence after the procedure. One major reason is that the mechanisms that maintain AF are not fully understood. Research suggests that the outer layer of the heart (epicardium) may play an important role in keeping AF going. However, current mapping techniques have limitations in detecting electrical signals from both the inner and outer heart layers. This study uses a different technique called unipolar voltage mapping, which may more accurately capture electrical signals from both heart layers. Specifically, we focus on a specific type of electrical signal called "QS potential" on unipolar mapping, which reflects breakthrough sites between the inner and outer heart layers. In this interventional study, participants with AF undergoing catheter ablation will receive personalized ablation guided by unipolar QS-potential mapping. We aim to: Explore the relationship between unipolar QS-potentials and AF maintenance and atrial remodeling Evaluate the effectiveness of QS-potential guided personalized AF ablation
Trial Details
NCT Number NCT07630857
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions Atrial Fibrillation (AF)
Enrollment 200 participants
Start Date 2026-06-20
Primary Completion 2026-09-19 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-05